NCT05229497 2026-03-09
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
Akeso
Phase 1/2 Active not recruiting
Clinical Trials
13 trialsNCT06167486 2026-03-09
SG2918 For Advanced Malignant Tumors
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1 Active not recruiting
NCT05214482 2026-03-03
A Study of AK112 in Advanced Malignant Tumors
Akeso
Phase 1/2 Completed
NCT07409766 2026-02-13
A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Not yet recruiting
NCT07038005 2026-02-09
A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT05223231 2026-02-02
Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
NCT06877650 2026-01-29
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Shanghai JMT-Bio Inc.
Phase 1/2 Recruiting
NCT07016490 2026-01-28
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT07043751 2026-01-21
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT07338838 2026-01-14
To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT07032298 2025-07-25
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1 Recruiting
NCT05102006 2025-06-03
A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
NCT05779163 2025-05-07
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting